Clinical management of pulmonary sarcoidosis.

Abstract:

:Sarcoidosis is a multisystem disease for which diagnosis relies on the integration of clinical, radiologic, laboratory, and pathologic information. Assessment of clinical features is an important part of the disease evaluation. Computer Tomography provides information not available on routine chest roentgenogram which can assist diagnosing and establishing extent of disease. Monitoring for pulmonary and extra-pulmonary disease facilitates disease management. Patients with quality of life affecting symptoms or threatened end organ damage require systemic treatment which can be recommended in a stepwise fashion. Here, we provide guidance for the initial assessment, disease monitoring, and treatment recommendations for pulmonary and extra pulmonary disease.

journal_name

Expert Rev Respir Med

authors

Zhou Y,Lower EE,Li H,Baughman RP

doi

10.1586/17476348.2016.1164602

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

577-91

issue

5

eissn

1747-6348

issn

1747-6356

journal_volume

10

pub_type

杂志文章,评审
  • Exploring the clinical relevance of cough hypersensitivity syndrome.

    abstract::Introduction: Knowledge of the pathophysiology of cough has continued to advance over recent decades. Establishing anatomic-diagnostic protocols, based on the anatomy and distribution of vagus nerve pathways regulating the cough reflex, was the first breakthrough in modern clinical medicine for chronic cough. The unme...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2020.1713102

    authors: Song WJ,Chung KF

    更新日期:2020-03-01 00:00:00

  • Perspectives in adjuvant chemotherapy in NSCLC.

    abstract::In 2007 the long-term outcome of lung cancer is still disappointing, with a 5-year survival rate not exceeding 15%. However, small but significant improvements in survival times have been achieved in the last decade. This progress has been achieved through the improvement of surgical techniques and following the intro...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.1.1.99

    authors: Selvaggi G,Scagliotti GV

    更新日期:2007-08-01 00:00:00

  • The management of infection with Mycobacterium tuberculosis in young children post-2015: an opportunity to close the policy-practice gap.

    abstract:INTRODUCTION:The treatment of infection with Mycobacterium tuberculosis in young children is supported by universal policy based on strong rationale and evidence of effectiveness, but has rarely been implemented in tuberculosis endemic countries. Areas covered: This review highlights a number of important recent develo...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2016.1267572

    authors: Graham SM

    更新日期:2017-01-01 00:00:00

  • Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers.

    abstract::Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized by persistent airflow limitation. It is the third leading cause of death worldwide, and there are currently no curative strategies for this disease. Many factors contribute to COPD susceptibility, progression and exacerbations. These...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2013.842468

    authors: Goh F,Shaw JG,Savarimuthu Francis SM,Vaughan A,Morrison L,Relan V,Marshall HM,Dent AG,O'Hare PE,Hsiao A,Bowman RV,Fong KM,Yang IA

    更新日期:2013-12-01 00:00:00

  • Emerging biomarkers of lymphangioleiomyomatosis.

    abstract:INTRODUCTION:Lymphangioleiomyomatosis (LAM) is a destructive lung disease affecting primarily women. LAM is caused by inactivating mutations in the tuberous sclerosis complex (TSC) genes, resulting in hyperactivation of mechanistic/mammalian target of rapamycin complex 1 (mTORC1). Over the past five years, there have b...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1409622

    authors: Nijmeh J,El-Chemaly S,Henske EP

    更新日期:2018-02-01 00:00:00

  • Dust-mite inducing asthma: what advice can be given to patients?

    abstract::Introduction: Amongst allergic asthmatics, high allergen exposure increases asthma severity. However, there is no consensus on the role of mite allergen avoidance in the management of asthma, and various guidelines differ in their recommendations. Areas covered: Several systematic reviews/meta-analyses on mite avoidan...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2019.1651647

    authors: Custovic A,Murray CS,Simpson A

    更新日期:2019-10-01 00:00:00

  • Physical functional capacity in idiopathic pulmonary fibrosis: performance characteristics of the continuous-scale physical function performance test.

    abstract:BACKGROUND:Physical functional capacity is impaired in idiopathic pulmonary fibrosis (IPF). There is no tool to measure this key clinical outcome. The continuous-scale physical function performance (CS-PFP) test is one that assesses activities of daily living, but it has never been used in IPF. METHODS:We determined i...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.2015.1030396

    authors: Olson AL,Swigris JJ,Belkin A,Hannen L,Yagihashi K,Schenkman M,Brown KK

    更新日期:2015-06-01 00:00:00

  • Surgical and non-surgical management of malignant pleural effusions.

    abstract:INTRODUCTION:Optimal management of malignant pleural effusion (MPE) is important in the care of patients with advanced cancer. Surgical (especially video-assisted thoracoscopic surgery (VATS)) and non-surgical strategies are available. Clinicians should be aware of the evidence supporting the use of different modalitie...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1398085

    authors: Fitzgerald DB,Koegelenberg CFN,Yasufuku K,Lee YCG

    更新日期:2018-01-01 00:00:00

  • Aerosolized antibiotics in cystic fibrosis: an update.

    abstract::Inhaled antibiotic therapy, targeting Pseudomonas aeruginosa, is a fundamental component of cystic fibrosis (CF) management. Tobramycin inhalation solution (TIS) was approved in the United States (US) in 1998. Subsequent research efforts focused on developing products with a reduced treatment time burden. Aztreonam fo...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2014.896205

    authors: Fiel SB

    更新日期:2014-06-01 00:00:00

  • Infection in cystic fibrosis: impact of the environment and climate.

    abstract::In many countries numbers of adults with cystic fibrosis (CF) exceed that of children, with median survival predicted to surpass 50 years. Increasing longevity is, in part, due to intensive therapies including eradication of early infection and suppressive therapies and pulmonary exacerbations. Initial infections with...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2016.1162715

    authors: Ramsay KA,Stockwell RE,Bell SC,Kidd TJ

    更新日期:2016-01-01 00:00:00

  • Unmet needs in cystic fibrosis: the next steps in improving outcomes.

    abstract:INTRODUCTION:Cystic fibrosis (CF) outcomes and survival have improved over the last century primarily due to advancements in antibiotics, nutritional, and pulmonary therapies. Reviewed here are the significant unmet needs that exist for individuals with CF. Areas covered: With the recent development of medications that...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1483723

    authors: West NE,Flume PA

    更新日期:2018-07-01 00:00:00

  • Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention.

    abstract::Premature infants are at substantial risk for a spectrum of morbidities that are gestational age dependent. Respiratory syncytial virus (RSV) infection is most common in the first two years of life with the highest burden in children aged <6 months. Preterm infants ≤35 weeks' gestation are handicapped by incomplete im...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2015.1098536

    authors: Abraha HY,Lanctôt KL,Paes B

    更新日期:2015-01-01 00:00:00

  • Therapy for cough: where does it fall short?

    abstract::Studies on cough have come a long way but many shortfalls still exist. These shortfalls can be attributed to: the lack of randomized controlled studies with a focus on cough; studies not using robust cough outcome measures, poor definition of target groups in studies and guidelines, the lack of safe and efficacious tr...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.11.35

    authors: Chang AB

    更新日期:2011-08-01 00:00:00

  • Vitamin D and omega-3 polyunsaturated fatty acid supplementation in athletes with exercise-induced bronchoconstriction: a pilot study.

    abstract:OBJECTIVE:The aim of this pilot study was to determine the combined effect of vitamin D and omega-3 polyunsaturated fatty acid (PUFA) supplementation on airway function and inflammation in recreational athletes with exercise-induced bronchoconstriction (EIB). METHODS:Ten recreational athletes with EIB participated in ...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.2015.1036032

    authors: Price OJ,Hull JH,Howatson G,Robson-Ansley P,Ansley L

    更新日期:2015-06-01 00:00:00

  • The pragmatic role of FEF25-75 in asymptomatic subjects, allergic rhinitis, asthma, and in military setting.

    abstract::Introduction: The forced expiratory flow between 25% and 75% of forced vital capacity (FEF25-75) is a spirometry parameter that may be useful in many clinical settings. Values <65% of predicted have been defined as abnormal.Areas covered: The current report discusses the clinical value of FEF25-75 in different setting...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2019.1674649

    authors: Ciprandi G,Cirillo I

    更新日期:2019-12-01 00:00:00

  • Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease.

    abstract::Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and a scavenging effect on free oxidant radicals. Erdosteine is a prodrug and metabolite I is the active metabolite of erdoste...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.1.3.307

    authors: Moretti M

    更新日期:2007-12-01 00:00:00

  • Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?

    abstract:INTRODUCTION:There is an ongoing need for additional interventions in idiopathic pulmonary fibrosis (IPF) as antifibrotic drugs currently available only inhibit and do not stall disease progression. Vitamin K is a co-factor for the activation of coagulation factors. However, it is also required to activate proteins wit...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2018.1424544

    authors: De Brouwer B,Piscaer I,Von Der Thusen JH,Grutters JC,Schutgens RE,Wouters EF,Janssen R

    更新日期:2018-03-01 00:00:00

  • What is the importance of classifying Aspergillus disease in cystic fibrosis patients?

    abstract::Aspergillus species are commonly isolated from lower respiratory tract samples of patients with cystic fibrosis (CF) and markers of immunological sensation to Aspergillus are frequently encountered in this group of patients; however, the contribution of Aspergillus to CF lung disease outside of the typical complicatio...

    journal_title:Expert review of respiratory medicine

    pub_type: 社论

    doi:10.1586/17476348.2014.915751

    authors: Jones AM,Horsley A,Denning DW

    更新日期:2014-08-01 00:00:00

  • Bronchiolitis: adopting a unifying definition and a comprehensive etiological classification.

    abstract::Bronchiolitis is an inflammatory and potentially fibrosing condition affecting mainly the intralobular conducting and transitional small airways. Secondary bronchiolitis participates in disease process of the airways and/or the surrounding lobular structures in the setting of several already defined clinical entities,...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.13.21

    authors: Papiris SA,Malagari K,Manali ED,Kolilekas L,Triantafillidou C,Baou K,Rontogianni D,Bouros D,Kagouridis K

    更新日期:2013-06-01 00:00:00

  • Therapeutic targets for inflammation-mediated airway remodeling in chronic lung disease.

    abstract:INTRODUCTION:Acute exacerbations of chronic lung disease account for substantial morbidity and health costs. Repeated inflammatory episodes and attendant bronchoconstriction cause structural remodeling of the airway. Remodeling is a multicellular response to mucosal injury that results in epithelial cell-state changes,...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1526677

    authors: Brasier AR

    更新日期:2018-11-01 00:00:00

  • Allergic airway inflammation: unravelling the relationship between IL-37, IL-18Rα and Tir8/SIGIRR.

    abstract::The hallmarks of allergic bronchial asthma arise from chronic airway inflammation. Thus, elucidating the mechanisms regulating the maintenance of this chronic inflammatory response is key to understanding asthma pathogenesis. To date, it is not clear whether a predominance of proinflammatory factors or a reduced capac...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2015.1109452

    authors: Lunding L,Schröder A,Wegmann M

    更新日期:2015-01-01 00:00:00

  • Long-term oxygen therapy.

    abstract::Long-term oxygen therapy (LTOT) has been shown to reduce pulmonary hypertension and improve survival in patients with chronic obstructive pulmonary disease and resting hypoxemia (reduced arterial partial pressure of oxygen ≤55 mmHg). However, the benefit of its use for chronic pulmonary diseases other than chronic obs...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.12.69

    authors: Jindal SK,Agarwal R

    更新日期:2012-12-01 00:00:00

  • Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma.

    abstract::Reslizumab, a neutralizing anti-IL-5 monoclonal antibody, is a promising adjunctive treatment for severe eosinophilic asthma. Monthly intravenous 3.0 mg/kg reslizumab had resulted in improvements in lung function and asthma control. It is well tolerated and common adverse events include headache, nasopharyngitis and u...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2015.1000867

    authors: Lim HF,Nair P

    更新日期:2015-04-01 00:00:00

  • The long-lasting effects of the acute respiratory distress syndrome.

    abstract::Introduction: Acute respiratory distress syndrome (ARDS) is a severe form of acute lung injury common in critically ill patients and characterized by significant morbidity and mortality. It frequently manifests long-lasting effects beyond hospitalization, from cognitive impairment to physical weakness.Areas covered: S...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2020.1743182

    authors: Mart MF,Ware LB

    更新日期:2020-06-01 00:00:00

  • Recent advances in optical coherence tomography for the diagnoses of lung disorders.

    abstract::There have been many advances in the field of diagnostic and therapeutic pulmonary medicine in the past several years, with major progress in the field of imaging. Optical coherence tomography (OCT) is a high-resolution (micron level) imaging modality currently being advanced with the potential to image airway wall st...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.11.59

    authors: Hou R,Le T,Murgu SD,Chen Z,Brenner M

    更新日期:2011-10-01 00:00:00

  • The physical basis of ventilator-induced lung injury.

    abstract::Although mechanical ventilation (MV) is a life-saving intervention for patients with acute respiratory distress syndrome (ARDS), it can aggravate or cause lung injury, known as ventilator-induced lung injury (VILI). The biophysical characteristics of heterogeneously injured ARDS lungs increase the parenchymal stress a...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.10.28

    authors: Plataki M,Hubmayr RD

    更新日期:2010-06-01 00:00:00

  • Recent advances in pediatric asthma treatment.

    abstract::Although wheezing illness is at its most prevalent in infancy and early childhood, its self-limiting nature in the majority poses considerable challenges in offering a long-term prognosis and in initiating long-term prophylaxis. Many of the established treatments in adults have not been adequately assessed in children...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/ers.09.2

    authors: Helms PJ

    更新日期:2009-04-01 00:00:00

  • Advances in airway clearance technologies for chronic obstructive pulmonary disease.

    abstract::Techniques to promote clearance of sputum from the airways (airway clearance techniques; ACTs) have existed in clinical practice for more than a century. This review examines current evidence and clinical recommendations regarding ACTs for individuals with chronic obstructive pulmonary disease. Comparisons between thi...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2013.847368

    authors: Osadnik CR,McDonald CF,Holland AE

    更新日期:2013-12-01 00:00:00

  • Emerging pharmacotherapies in cystic fibrosis.

    abstract:INTRODUCTION:Cystic fibrosis (CF) is an autosomal dominant chloride channelopathy caused by mutations in the CF transmembrane conductance regulator (CFTR) gene that results clinically in a multisystem disorder. The major source of morbidity and mortality in CF is lung disease, which is characterized by recurrent cycles...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1512409

    authors: McElvaney OJ,Gunaratnam C,McElvaney OF,Bagwe I,Reeves EP,McElvaney NG

    更新日期:2018-10-01 00:00:00

  • Home oxygen therapy: evidence versus reality.

    abstract:INTRODUCTION:LTOT is a well-established treatment option for hypoxemic patients. Scientific evidence for its benefits of LTOT dates back to the 1980s, when two randomized controlled trials showed prolonged survival in COPD-patients undergoing LTOT for at least 15 hours/day. In contrast, the potential benefits of LTOT i...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2017.1325323

    authors: Magnet FS,Storre JH,Windisch W

    更新日期:2017-06-01 00:00:00